Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Breaking: Helus’ Deuterated Psilocin Hits Primary Endpoint in First Phase 3
Podcast: Compass Files Psilocybin Application with FDA, U.S. Government Taps Mark Cuban to Develop Ibogaine, Psychedelics After the Midterms
Field Notes #6: Dispatches from D.C. as Three Psychedelics Land at FDA
Breaking: U.S. Government Taps Mark Cuban’s Company to Develop Ibogaine for PTSD; Commits to Fund $20M Real-World Evidence Network
220 Patients or 20,000? Clinics Split on Psychedelics’ First Year
Robert Rush: Emergency Scheduling, 7-OH, and the War on Research
Breaking: Compass Files Psilocybin for TRD New Drug Application with FDA
The Problems We Will Be Lucky to Have
Pα+ Psychedelic Bulletin #234: Psychedelics After the Midterms; FDA Answers House...
Is It Worth It? What Colorado’s Early Experience With Regulated Psychedelic...
Compass Says NDA Will Be Filed Within Two Weeks, Declines to...
Podcast: Usona Files Psilocybin Application, We Review 610 Comments Submitted to...
Usona Files Psilocybin for Depression NDA as Race With Compass Tightens
Jackie Tileston: Nondual Mysticism, 5-MeO-DMT, and the Trouble with Psychedelic Art
FDA Approves NRx’s Preservative-Free Generic Ketamine, but Its Bid to Ban...
Load more